Wealth Enhancement Advisory Services LLC Takes $308,000 Position in Constellium SE $CSTM

Wealth Enhancement Advisory Services LLC bought a new stake in Constellium SE (NYSE:CSTMFree Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 21,164 shares of the industrial products company’s stock, valued at approximately $308,000.

A number of other institutional investors have also modified their holdings of CSTM. GAMMA Investing LLC grew its position in shares of Constellium by 2,485.6% in the 1st quarter. GAMMA Investing LLC now owns 2,689 shares of the industrial products company’s stock worth $27,000 after acquiring an additional 2,585 shares in the last quarter. Harvest Fund Management Co. Ltd acquired a new position in shares of Constellium in the 1st quarter worth approximately $38,000. US Bancorp DE grew its position in shares of Constellium by 1,034.7% in the 1st quarter. US Bancorp DE now owns 5,163 shares of the industrial products company’s stock worth $52,000 after acquiring an additional 4,708 shares in the last quarter. Signaturefd LLC grew its position in shares of Constellium by 20.3% in the 1st quarter. Signaturefd LLC now owns 6,002 shares of the industrial products company’s stock worth $61,000 after acquiring an additional 1,013 shares in the last quarter. Finally, CWM LLC grew its position in shares of Constellium by 91.5% in the 1st quarter. CWM LLC now owns 6,842 shares of the industrial products company’s stock worth $69,000 after acquiring an additional 3,269 shares in the last quarter. Institutional investors and hedge funds own 92.59% of the company’s stock.

Constellium Price Performance

NYSE CSTM opened at $15.02 on Thursday. Constellium SE has a 52 week low of $7.32 and a 52 week high of $16.49. The company has a current ratio of 1.23, a quick ratio of 0.53 and a debt-to-equity ratio of 2.47. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 79.06 and a beta of 1.71. The company has a 50-day moving average price of $14.51 and a two-hundred day moving average price of $12.74.

Constellium (NYSE:CSTMGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by ($0.03). The company had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.08 billion. Constellium had a net margin of 0.37% and a return on equity of 3.43%. Analysts forecast that Constellium SE will post 1.1 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Wells Fargo & Company initiated coverage on Constellium in a research report on Wednesday. They issued an “equal weight” rating and a $16.00 target price for the company. Zacks Research downgraded shares of Constellium from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 2nd. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Constellium in a research report on Wednesday. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Constellium presently has a consensus rating of “Hold” and a consensus price target of $18.25.

Get Our Latest Report on Constellium

About Constellium

(Free Report)

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

Recommended Stories

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)

Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.